Innate and adaptive immunity in the human female reproductive tract: Influence of the menstrual cycle and menopause on the mucosal immune system in the uterus

The Endometrium: Molecular, Cellular and Clinical Perspectives, Second Edition

Volumn , Issue , 2008, Pages 493-523

  Wira, Charles R ^a   Fahey, John V ^a   Schaefer, Todd M ^a   Pioli, Patricia A ^a   Sentman, Charles L ^a   Shen, Li ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84939551736     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (310)

1. Ogra P, Yamanaka T, Losonsky GA. Local immunologic defenses in the genital tract. In: Fleicher N, ed. Reprod Immunol. New York: Alan R Liss, 1981: 381-94.
2. Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986; 4: 389-417.
3. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40: 153-245.
4. Wira CR, Fahey JV, White HD et al. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Guidice L, Tabibzadeh S, eds. The Endometrium. New York: Taylor and Francis, 2002: 371-404.
5. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985; 227: 257-61.
6. Wira CR, Richardson J, Prabhala R. Endocrine regulation of mucosal immunity: effect of sex hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract. In: Ogra PL, Mestecky J, Lamm ME et al, eds. Handbook of Mucosal Immunology. New York: Academic Press, 1994: 705-18.
7. Kutteh WH, Mestecky J, Wira CR. Mucosal immunity in the human female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME eds. Mucosal Immunology. New York: Academic Press, 2005: 1631-47.
8. Medzhitov RM, Janeway CJ. Innate immunity. N Engl J Med 2000; 343: 338-44.
9. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
10. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499-511.
11. Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 247: 33419-25.
12. da Silva Correia J, Soldau K, Christen U et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 267: 21129-2135.
13. Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-103.
14. Muroi M, Ohnishi T, Azumi-Mayuzumi S et al. Lipopolysaccharide- mimetic activities of a Toll-like receptor 2-stimulatory substance(s) in enterobacterial lipopolysaccharide preparations. Infect Immun 2003; 71: 3221-6.
15. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-51.
16. Alexopoulou L, Holt AC, Medzhitov R et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-8.
17. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3: 196-200.
18. Jurk M, Heil F, Vollmer J et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3: 499.
19. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2002; 408: 740-5.
20. Wira CR, Stern J. Endocrine regulation of the mucosal immune system in the female reproductive tract: control of IgA, IgG, and secretory component during the reproductive cycle, at implantation and throughout pregnancy. In: Pasqualini JR, Scholler R, eds. Hormones and Fetal Pathophysiology. New York: Marcel Dekker, 1992: 343-68.
21. Cates W. Priorities for sexually transmitted diseases in the late 1980s and beyond. Sex Trans Dis 1986; 13: 114-17.
22. Piot P, Plummer FA, Mhalu FS et al. AIDS: an international perspective. Science 1988; 239: 573-9.
23. Peterman TA, Curran JW. Sexual transmission of human immunodeficiency virus. JAMA 1986; 256: 2222-6.
24. Harris C, Small CB, Klein RS et al. Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med 1983; 308: 1181-4.
25. Calabrese LH, Gopalakrishna KV. Transmission of HTLV-III infection from man to woman to man. N Engl J Med 1986; 314: 987.
26. Ho DD, Schooley RT, Rota TR et al. HTLV-III in the semen and blood of a healthy homosexual man. Science 1984; 226: 451-3.
27. Vogt MW, Witt DJ, Craven DE et al. Isolation of HTLVIII/LAV from cervical secretions of women at risk for AIDS. Lancet 1986; 1: 525-7.
28. Vogt MW, Witt DJ, Craven DE et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for AIDS. Ann Intern Med 1987; 106: 380-2.
29. Wofsy CB, Cohen JB, Hauer LB et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1: 527-9.
30. McDonough PG. Comment. Fertil Steril 1987; 48: 704.
31. Alexander NJ, Anderson DJ. Immunology of semen. Fertil Steril 1987; 47: 192-205.
32. Bronson RA. Immunology. In: Seibel MM, ed. Infertility: A Comprehensive Text. Norwalk, CT: Appleton and Lange, 1990: 217-34.
33. Allardyce RA. Effect of ingested sperm on fecundity in the rat. J Exp Med 1984; 159: 1548-53.
34. Allardyce R, Rademaker M. Female genital tract immunity and infertility after oral vaccination with sperm antigens in mice. Adv Exp Med Biol 1987; 216B: 1807-13.
35. Dahlenbach-Hellweg G. Histopathology of the Endometrium. New York: Springer-Verlag, 1975.
36. Morris H, Edwards J, Tiltman A et al. Endometrial lymphoid tissue: an immunohistological study. J Clin Pathol 1985; 38: 644-52.
37. Bulmer JN, Earl U. The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle. Immunology 1987; 61: 207-13.
38. Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod 1994; 50: 461-6.
39. Chen CK, Huang SC, Chen CL et al. Increased expressions of CD69 and HLA-DR but not of CD25 or CD71 on endometrial T lymphocytes of nonpregnant women. Human Immunol 1995; 42: 227-32.
40. Lachapelle MH, Miron P, Hemmings R et al. Flow-cytometric characterization of hematopoietic cells in non-pregnant human endometrium. Am J Reprod Immunol 1996; 35: 5-13.
41. Lachapelle MH, Miron P, Hemmings R et al. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-34.
42. Kamat BR, Isaacson PG. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987; 127: 66-73.
43. Hameed A, Fox WM, Kurman RJ et al. Perforin expression in endometrium during the menstrual cycle. Int J Gynecol Pathol 1995; 14: 143-50.
44. Loke YW, King A. Human Implantation: Cell Biology and Immunology. Cambridge: Cambridge University Press, 1995.
45. Bulmer JN. Cellular constituents of human endometrium in the menstrual cycle and early pregnancy. In: Bronson RA, Alexander NJ, Anderson D, Branch DW, Kutteh WH, eds. Reprod Immunol. Cambridge, MA: Blackwell Science, 1996: 212-39.
46. Givan AL, White HD, Stern JE et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of Fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997; 38: 350-9.
47. Tabibzadeh S. Proliferative activity of lymphoid cells in the human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1990; 70: 437-43.
48. 8+T cell-rich lymphoid aggregates in human uterine endometrium. J Leuk Biol 1997; 61: 427-35.
49. 8+T cells in human uterine endometrial lymphoid aggregates shows no clonal restriction: evidence that uterine lymphoid aggregates arise by cell trafficking. Immunology 2001; 102: 434-40.
50. Parr MB, Parr EL. Mucosal immunity in the female and male reproductive tracts. In: Ogra PL, Mestecky J, Lamm ME et al, eds. Handbook of Mucosal Immunology. New York: Academic Press, 1994: 677-89.
51. Lippes J, Ogra S, Tomasi TBJ et al. Immunohistochemical localization of γG, γA, γM, secretory piece and lactoferrin in the human female genital tract. Contraception 1970; 1: 163.
52. Rebello R, Green F, Fox H. A study of the secretory immune system of the female genital tract. J Obstet Gynecol 1975; 82: 812-16.
53. Kelly JK, Fox H. The local immunological defense system of the human endometrium. J Reprod Immunol 1979; 1: 39-45.
54. Tourville DR, Ogra SS, Lippes J, Tomasi TB. The human female reproductive tract: immunohistological localization of γA, γG, γM, secretory ‘piece’ and lactoferrin. Am J Obstet Gynecol 1970; 108: 1102-8.
55. Wira CR, Sandoe CP. Sex steroid hormone regulation of IgA and IgG in rat uterine secretions. Nature 1977; 268: 534-6.
56. Wira CR, Hyde E, Sandoe CP et al. Cellular aspects of the rat uterine IgA response to estradiol and progesterone. J Steroid Biochem 1980; 12: 451-9.
57. Sullivan DA, Underdown BJ, Wira CR. Steroid hormone regulation of free secretory component in the rat uterus. Immunology 1983; 49: 379-86.
58. Wira CR, Sullivan DA. Estradiol and progesterone regulation of IgA, IgG and secretory component in cervico-vaginal secretions of the rat. Biol Reprod 1985; 32: 90-5.
59. Wira CR, Sandoe CP. Hormone regulation of immunoglobulins: influence of estradiol on IgA and IgG in the rat uterus. Endocrinology 1980; 106: 1020-6.
60. Kaushic C, Richardson JM, Wira CR. Regulation of polymeric immunoglobulin. A receptor messenger ribonucleic acid expression in rodent uteri: effect of sex hormones. Endocrinology 1995; 136: 2836-44.
61. Kaushic C, Frauendorf E, Wira CR. Polymeric immunoglobulin. A receptor in the rodent female reproductive tract: expression in vagina and tissue specific mRNA regulation by sex hormones. Biol Reprod 1997; 57: 958-66.
62. Tauber PF, Wettich W, Nohlen M et al. Diffusible proteins of the mucosa of the human cervix, uterus, and fallopian tubes: distribution and variations during the menstrual cycle. Am J Obstet Gynecol 1985; 15: 1115-25.
63. Schumacher GFB. Humoral immune factors in the female reproductive tract and their changes during the cycle. In: Dinsda D, Schumacher G, eds. Immunological Aspects of Infertility and Fertility Control. North Holland: Elsevier, 1980: 93-141.
64. Brandtzaeg P. Transport models for secretory IgA and IgM. Clin Exp Immunol 1981; 44: 221-32.
65. Vaerman J-P, Férin J. Local immunological response in the vagina, cervix and endometrium. Acta Endocrinol 1974; 194: 281-305.
66. Ganguly RCD, Waldman RH. Local immunity and local immune responses. Prog Allergy 1980; 27: 1-68.
67. South MS. In: Ogra PL, Dayton DH, eds. Immunology of Breast Milk. New York: Raven Press, 1979: 193.
68. Crago SS, Kulhavy R, Prince SJ et al. Inhibition of the pokeweed mitogen-induced response of normal peripheral blood lymphocytes by humoral components of colostrum. Clin Exp Immunol 1981; 45: 386-92.
69. Wira CR, Sandoe CP. Origin of IgA and IgG antibodies in the female reproductive tract: regulation of the genital response by estradiol. Adv Exp Med Biol 1987; 216A: 403-12.
70. Richardson J, Kaushic C, Wira CR. Estradiol regulation of secretory component: expression by rat uterine epithelial cells. J Steroid Biochem 1993; 47: 143-9.
71. Menge AC, Mestecky J. Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines. J Clin Immunol 1993; 13: 259-64.
72. Menge AC, Naz RK. Immunoglobulin (Ig) G, IgA, and IgA subclass antibodies against fertilization antigen-1 in cervical secretions and sera of women of infertile couples. Fertil Steril 1993; 60: 658-63.
73. Wira CR, Stern JE, Colby E. Estradiol regulation of secretory component in the uterus of the rat: evidence for involvement of RNA synthesis. J Immunol 1984; 133: 2624-8.
74. Richardson JM, Kaushic C, Wira CR. Polymeric immunoglobulin (Ig) receptor production and IgA transcytosis in polarized primary cultures of mature rat uterine epithelial cells. Biol Reprod 1995; 53: 488-98.
75. Fahey JV, Humphrey SL, Stern JE et al. Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol Invest 1998; 27: 167-80.
76. Hurlimann J, Dayal R, Gloor E. Immunoglobulins and secretory component in endometrium and cervix: influence of inflammation and carcinoma. Virch Arch Path Anat Histol 1978; 377: 211-23.
77. Sullivan DA, Wira CR. Hormonal regulation of immunoglobulins in the rat uterus: uterine response to a single estradiol treatment. Endocrinology 1983; 112: 260-8.
78. Sullivan DA, Wira CR. Hormonal regulation of immunoglobulins in the rat uterus: Uterine response to multiple estradiol treatments. Endocrinology 1984; 114: 650-8.
79. Sullivan DA, Wira CR. Variations in free secretory component levels in mucosal secretions of the rat. J Immunol 1983; 130: 1330-5.
80. Lohman BL, Miller CJ, McChesney MB. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995; 155: 5855-60.
81. Musey L, Hu Y, Eckert L et al. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997; 185: 293-303.
82. 8+CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158: 3017-27.
83. White HD, Crassi K, Wira CR. Cytolytic functional activities of NK cells and cytotoxic T lymphocytes (CTL) are coordinately regulated in the human female reproductive tract. In: Husband AJ, Beagley KW, Clancey RL et al, eds. Mucosal Solutions: Advances in Mucosal Immunology. Sydney, Australia: The University of Sydney, 1997; 1: 385-91.
84. Ogra PL, Ogra SS. Local antibody response to poliovaccine in the human female genital tract. J Immunol 1973; 110: 1307-11.
85. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005; 23: 975-1028.
86. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-7.
87. Lechler R, Aichinger G, Lightstone L. The endogenous pathway of MHC class II antigen presentation. Immunol Rev 1996; 151: 51-79.
88. Reyes VE, Ye G, Ogra PL et al. Antigen presentation of mucosal pathogens: the players and the rules. Int Arch Allergy Immunol 1997; 112: 103-14.
89. Lawton AP, Kronenberg M. The third way: progress on pathways of antigen processing and presentation by CD1. Immunol Cell Biol 2004; 82: 295-306.
90. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004; 21: 733-41.
91. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005; 560: 11-18.
92. Pasare C, Medzhitov R. Control of B-cell responses by Tolllike receptors. Nature 2005; 438: 364-8.
93. van Duin D, Medzitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol 2006; 27: 49-55.
94. Prabhala RH, Wira CR. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995; 155: 5566-73.
95. Wira CR, Rossoll RM. Antigen presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 1995; 136: 4526-34.
96. Wira CR, Rossoll RM. Antigen presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995; 84: 505-8.
97. Wira CR, Rossoll RM, Kaushic C. Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology 2000; 141: 2877-85.
98. Wira CR, Roche MA, Rossoll RM. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 2002; 143: 2872-9.
99. Wira CR, Rossoll RM. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen- presenting cell function. Immunology 2003; 109: 398-406.
100. Wira C, Rossoll R, Young R. Polarized uterine epithelial cells preferentially present antigen at the basolateral surface: role of stromal cells in regulating class II-mediated epithelial cell antigen presentation. J Immunol 2005; 175: 1795-804.
101. Wira CR, Grant-Tschudy KS, Crane-Godreau M. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol 2005; 53: 1-12.
102. Head JR, Gaede SD. Ia antigen expression in the rat uterus. J Reprod Immunol 1986; 9: 137-53.
103. Bjercke S, Brandtzaeg P. Glandular distribution of immunoglobins, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle. Hum Reprod 1993; 8: 1420-5.
104. Wallace PK, Yeaman GR, Johnson K et al. MHC class II expression and antigen presentation by human endometrial cells. J Steroid Biochem Mol Biol 2001; 76: 203-11.
105. Fahey JV, Prabhala RH, Guyre PM et al. Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in pre- and post-menopausal women. Am J Reprod Immunol 1999; 42: 49-57.
106. Fahey JV, Wallace PK, Johnson K et al. Antigen presentation by human uterine epithelial cells to autologous T cells. Am J Reprod Immunol 2006; 55: 1-11.
107. Biancone L, Cantaluppi V, Camussi G. CD40-CD154 interaction in experimental and human disease (review). Int J Mol Med 1999; 3: 343-53.
108. Young LS, Eliopoulos AG, Gallagher NG et al. CD40 and epithelial cells: across the great divide. Immunol Today 1998; 19: 502-6.
109. Erlebacher A, Zhang D, Parlow AF et al. Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J Clin Invest 2004; 114: 39-48.
110. Jenkinson HJ, Wainwright SD, Simpson KL et al. Expression of CD1D mRNA transcripts in human choriocarcinoma cell lines and placentally derived trophoblast cells. Immunology 1999; 96: 649-55.
111. Mayer LF, Blumberg RS. Role of epithelial cells in mucosal antigen presentation. In: Mestecky J, Lamm ME, Strober W et al, eds. Mucosal Immunology. Boston, MA: Elsevier Academic Press, 2005; 1: 435-50.
112. Sallinen K, Verajankorva E, Pollanen P. Expression of antigens involved in the presentation of lipid antigens and induction of clonal anergy in the female reproductive tract. J Reprod Immunol 2000; 46: 91-101.
113. Wira CR, Fahey JV. The innate immune system: gatekeeper to the female reproductive tract. Immunology 2004; 111: 13-15.
114. Grant KS, Wira CR. Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol Reprod 2003; 69: 1091-8.
115. Ganz T, Lehrer RI. Defensins. Pharmacol Ther 1995; 66: 191-205.
116. Quayle AJ, Porter EM, Nussbaum AA et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152: 1247-58.
117. Valore EV, Park CH, Quayle AJ et al. Human β-defensin-1, an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101: 1633-42.
118. King AE, Fleming DC, Critchley HO et al. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod 2002; 8: 341-9.
119. King AE, Fleming DC, Critchley HO et al. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol 2003; 59: 1-16.
120. Denison FC, Kelly RW, Calder AA et al. Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: characterization of sites of release within the uterus. J Endocrinol 1999; 161: 299-306.
121. King AE, Morgan K, Sallenave JM et al. Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem Biophys Res Commun 2003; 310: 594-9.
122. King AE, Critchley HO, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod 2000; 6: 191-6.
123. Fleming DC, King AE, Williams AR et al. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril 2003; 79: 856-63.
124. Chen D, Xu X, Cheon YP et al. Estrogen induces expression of secretory leukocyte protease inhibitor in rat uterus. Biol Reprod 2004; 71: 508-14.
125. Ace CI, Okulicz WC. Microarray profiling of progesteroneregulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2004; 2: 54-60.
126. Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002; 57: 61-79.
127. Tabibzadeh S. Evidence of T-cell activation and potential cytokine action in human endometrium. J Clin Endocrinol Metab 1990; 71: 645-9.
128. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod 1996; 2: 77-92.
129. Dominguez F, Pellicer A, Simon C. Paracrine dialogue in implantation. Mol Cell Endocrinol 2002; 186: 175-81.
130. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002; 47: 213-21.
131. Critchley HO, Kelly RW, Brenner RM et al. The endocrinology of menstruation - a role for the immune system. Clin Endocrinol (Oxf) 2001; 55: 701-10.
132. Jacobsson B, Holst RM, Wennerholm UB et al. Monocyte chemotactic protein-1 in cervical and amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation, and preterm delivery. Am J Obstet Gynecol 2003; 189: 1161-7.
133. Matsuda Y, Kouno S, Nakano H. Effects of antibiotic treatment on the concentrations of interleukin-6 and interleukin-8 in cervicovaginal fluid. Fetal Diagn Ther 2002; 17: 228-32.
134. Goepfert AR, Goldenberg RL, Andrews WW et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. Am J Obstet Gynecol 2001; 184: 483-8.
135. Romero R, Chaiworapongsa T, Kuivaniemi H et al. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190: 1509-19.
136. Simhan HN, Caritis SN, Krohn MA et al. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003; 189: 560-7.
137. Schaefer TM, Fahey JV, Wright JA et al. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I: C). J Immunol 2005; 174: 992-1002.
138. Schaefer TM, Wright JA, Pioli PA et al. IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type 1 in uterine epithelial cells. J Immunol 2005; 175: 6509-16.
139. Fahey JV, Wira CR. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185: 1606-13.
140. Schaefer TM, Desouza K, Fahey JV et al. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112: 428-36.
141. Young SL, Lyddon TD, Jorgenson RL et al. Expression of Toll-like receptors in human endometrial epithelial cells and cell lines. Am J Reprod Immunol 2004; 52: 67-73.
142. Hirata T, Osuga Y, Hirota Y et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005; 90: 548-56.
143. Fahey JV, Schaefer TM, Channon JY et al. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 2005; 20: 1439-46.
144. Schaefer TM, Fahey JV, Wright JA et al. Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I: C). Am J Reprod Immunol 2005; 54: 193-202.
145. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol 1995; 101(Suppl 1): 5-6.
146. Yoshimura T, Leonard EJ. Human monocyte chemoattractant protein-1: structure and function. Cytokines 1992; 4: 131-52.
147. Shen L, Fahey JV, Hussey SB et al. Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. Cell Immunol 2004; 230: 23-32.
148. Meter RA, Fahey JV, Wira CW. Secretion of monocyte chemotactic protein (MCP)-1 by polarized human uterine epithelium directs monocyte migration in culture. Fertil Steril 2005; 84: 191-201.
149. Lomas DA, Stone SR, Llewellyn-Jones C et al. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 1995; 270: 23437-43.
150. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays 1999; 21: 17-28.
151. Brown EJ. The role of extracellular matrix proteins in the control of phagocytosis. J Leukoc Biol 1986; 39: 579-91.
152. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-60.
153. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317-27.
154. Faurschou M, Sorensen OE, Johnsen AH et al. Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochim Biophys Acta 2002; 1591: 29-35.
155. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999; 44: 1-27.
156. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-52.
157. Kelly RW, Illingworth P, Baldie G et al. Progesterone control of interleukin-8 production in endometrium and choriodecidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod 1994; 9: 253-8.
158. Godaly G, Bergsten G, Hang L et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001; 69: 899-906.
159. Yeaman GR, Collins JE, Currie JK et al. IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol 1998; 160: 5145-53.
160. Poropatich C, Rojas M, Silverberg SG. Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynecol Pathol 1987; 6: 230-4.
161. Arici A, Seli E, Senturk LM et al. Interleukin-8 in the human endometrium. J Clin Endocrinol Metab 1998; 83: 1783-7.
162. Critchley HO, Jones RL, Lea RG et al. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab 1999; 84: 240-8.
163. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000; 6: 16-27.
164. Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G. FEBS Lett 1989; 249: 353-6.
165. Salamonsen LA, Zhang J, Hampton A et al. Regulation of matrix metalloproteinases in human endometrium. Hum Reprod 2000; 15(Suppl 3): 112-19.
166. Owen CA, Campbell EJ. Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis. Semin Cell Biol 1995; 6: 367-76.
167. Daimon E, Wada Y. Role of neutrophils in matrix metalloproteinase activity in the preimplantation mouse uterus. Biol Reprod 2005; 73: 163-71.
168. Lathbury LJ, Salamonsen LA. In-vitro studies of the potential role of neutrophils in the process of menstruation. Mol Hum Reprod 2000; 6: 899-906.
169. Klein JB, Rane MJ, Scherzer JA et al. Granulocytemacrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J Immunol 2000; 164: 4286-91.
170. Theilgaard-Monch K, Knudsen S, Follin P et al. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 2004; 172: 7684-93.
171. Gargett CE, Lederman F, Heryanto B et al. Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod 2001; 16: 1065-75.
172. Heryanto B, Girling JE, Rogers PA. Intravascular neutrophils partially mediate the endometrial endothelial cell proliferative response to oestrogen in ovariectomized mice. Reproduction 2004; 127: 613-20.
173. Liu L, Mul FP, Lutter R et al. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction. Am J Respir Cell Mol Biol 1996; 15: 771-80.
174. Kidney JC, Proud D. Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am J Respir Cell Mol Biol 2000; 23: 389-95.
175. Mikamo H, Kawazoe K, Izumi K et al. Effects of long-term administration of roxithromycin on neutrophil count and interleukin-8 level in endometrial cavity subjected to pyometra. Chemotherapy 1997; 43: 148-52.
176. Kumaratilake LM, Ferrante A, Jaeger T et al. GM-CSFinduced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM-CSF and TNF. Parasite Immunol 1996; 18: 115-23.
177. Shen L, Smith JM, Shen Z et al. Differential regulation of neutrophil chemotaxis to IL-8 and fMLP by GM-CSF: lack of direct effect of oestradiol. Immunology 2006; 117: 205-12.
178. Giacomini G, Tabibzadeh SS, Satyaswaroop PG et al. Epithelial cells are the major source of biologically active granulocyte macrophage colony-stimulating factor in human endometrium. Hum Reprod 1995; 10: 3259-63.
179. Cassatella MA, Gasperini S, Russo MP. Cytokine expression and release by neutrophils. Ann NY Acad Sci 1997; 832: 233-42.
180. Kerr MA, Stocks SC. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem J 1992; 24: 811-26.
181. Gosselin EJ, Wardwell K, Rigby WF et al. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol 1993; 151: 1482-90.
182. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108 (Pt 6): 2369-79.
183. van der Meer A, Lukassen HG, van Lierop MJ et al. Membrane-bound HLA-G activates proliferation and interferon- gamma production by uterine natural killer cells. Mol Hum Reprod 2004; 10: 189-95.
184. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001; 167: 1877-81.
185. Ashkar AA, Black GP, Wei Q et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003; 171: 2937-44.
186. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-74.
187. Kumar V, McNerney ME. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol 2005; 5: 363-74.
188. Biron CA, Nguyen KB, Pien GC et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
189. Ferlazzo G, Morandi B, D’Agostino A et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003; 33: 306-13.
190. Scott MJ, Hoth JJ, Gardner SA et al. Natural killer cell activation primes macrophages to clear bacterial infection. Am Surg 2003; 69: 679-86; discussion 686-7.
191. Koopman LA, Kopcow HD, Rybalov B et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-12.
192. Eriksson M, Meadows SK, Wira CR et al. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 2004; 76: 667-75.
193. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2: 656-63.
194. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-40.
195. King A, Wellings V, Gardner L et al. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989; 24: 195-205.
196. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol 2005; 42: 511-21.
197. Kitaya K, Nakayama T, Okubo T et al. Expression of macrophage inflammatory protein-1beta in human endometrium: its role in endometrial recruitment of natural killer cells. J Clin Endocrinol Metab 2003; 88: 1809-14.
198. Sentman CL, Meadows SK, Wira CR et al. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173: 6760-6.
199. Kitaya K, Nakayama T, Daikoku N et al. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. J Clin Endocrinol Metab 2004; 89: 2470-6.
200. Daikoku N, Kitaya K, Nakayama T et al. Expression of macrophage inflammatory protein-3beta in human endometrium throughout the menstrual cycle. Fertil Steril 2004; 81(Suppl 1): 876-81.
201. Chantakru S, Miller C, Roach LE et al. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol 2002; 168: 22-8.
202. Hanna J, Wald O, Goldman-Wohl D et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 2003; 102: 1569-77.
203. Wu X, Jin LP, Yuan MM et al. Human first-trimester trophoblast cells recruit CD56bright CD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. J Immunol 2005; 175: 61-8.
204. Chantakru S, Kuziel WA, Maeda N et al. A study on the density and distribution of uterine natural killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1 alpha. J Reprod Immunol 2001; 49: 33-47.
205. Xie X, Kang Z, Anderson LN et al. Analysis of the contributions of L-selectin and CXCR3 in mediating leukocyte homing to pregnant mouse uterus. Am J Reprod Immunol 2005; 53: 1-12.
206. Jiang D, Liang J, Hodge J et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 2004; 114: 291-9.
207. Chalifour A, Jeannin P, Gauchat JF et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004; 104: 1778-83.
208. Sivori S, Falco M, Della Chiesa M et al. CpG and doublestranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101: 10116-21.
209. Hart OM, Athie-Morales V, O’Connor GM et al. TLR7/8- mediated activation of human NK cells results in accessory celldependent IFN-γ production. J Immunol 2005; 175: 1636-42.
210. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004; 16: 709-16.
211. Chen W, Wahl SM. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1999; 1: 1367-80.
212. Sentman CL, Wira CR, Ericksson M. NK cell function in the human female reproductive tract. Am J Reprod Immunol 2007; 57: 108-15.
213. Meadows SK, Eriksson M, Barber A et al. Human NK cell IFN-gamma production is regulated by endogenous TGFbeta. Int Immunopharmacol 2006; 6: 1020-8.
214. Laouar Y, Sutterwala FS, Gorelik L et al. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005; 6: 600-7.
215. Hiby SE, Walker JJ, O’Shaughnessy KM et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957-65.
216. Stein-Streilein J, Sonoda KH, Faunce D et al. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol 2000; 67: 488-94.
217. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984; 2: 283-318.
218. DeLoia JA, Stewart-Akers AM, Brekosky J et al. Effects of exogenous estrogen on uterine leukocyte recruitment. Fertil Steril 2002; 77: 548-54.
219. Jones RL, Kelly RW, Critchley HO. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 1997; 12: 1300-6.
220. Arici A, Senturk LM, Seli E et al. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 1999; 61: 85-90.
221. Jones RL, Hannan NJ, Kaitu’u TJ et al. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004; 89: 6155-67.
222. Carruba G, D’Agostino P, Miele M et al. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem 2003; 90: 187-96.
223. Vegeto E, Bonincontro C, Pollio G et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 21: 1809-18.
224. Lambert KC, Curran EM, Judy BM et al. Estrogen receptoralpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J Leukoc Biol 2004; 75: 1166-72.
225. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
226. Cella M, Scheidegger D, Palmer-Lehmann K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-52.
227. Bengtsson AK, Ryan EJ, Giordano D et al. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004; 104: 1404-10.
228. Driggers PH, Segars JH. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 2002; 13: 422-7.
229. Kammerer U, Schoppet M, McLellan AD et al. Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am J Pathol 2000; 157: 159-69.
230. Cameron P, Pope M, Granelli-Piperno A et al. Dendritic cells and the replication of HIV-1. J Leukoc Biol 1996; 59: 158-71.
231. Grouard G, Clark EA. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. Curr Opin Immunol 1997; 9: 563-7.
232. Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587-97.
233. Jameson B, Baribaud F, Pohlmann S et al. Expression of DCSIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76: 1866-75.
234. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52.
235. Dentener MA, Bazil V, Von Asmuth EJ et al. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factoralpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150: 2885-91.
236. Phiel KL, Henderson RA, Adelman SJ et al. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005; 97: 107-13.
237. Ashcroft GS, Mills SJ, Lei K et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003; 111: 1309-18.
238. Liebler JM, Kunkel SL, Burdick MD et al. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol 1994; 152: 241-9.
239. Adeyemo O, Jeyakumar H. Plasma progesterone, estradiol-17 beta and testosterone in maternal and cord blood, and maternal human chorionic gonadotropin at parturition. Afr J Med Med Sci 1993; 22: 55-60.
240. Sarda IR, Gorwill RH. Hormonal studies in pregnancy. I. Total unconjugated estrogens in maternal peripheral vein, cord vein, and cord artery serum at delivery. Am J Obstet Gynecol 1976; 124: 234-8.
241. Merkel SM, Alexander S, Zufall E et al. Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock. Infect Immun 2001; 69: 6119-22.
242. WHO. Global Prevalance and Incidence of Selected Curable Sexually Transmitted Infections. Overview and Estimates. Geneva: WHO, 2001.
243. Moodley P, Sturm AW. Sexually transmitted infections, adverse pregnancy outcome and neonatal infection. Semin Neonatol 2000; 5: 255-69.
244. UNAIDS/WHO 2005. AIDS Epidemic Update: Special Report on HIV Prevention. Geneva: WHO, 2005.
245. McEvedy C. The bubonic plague. Sci Am 1988; 258: 118-23.
246. Webster RG. The importance of animal influenza for human disease. Vaccine 2002; 20(Suppl 2): S16-20.
247. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ 1992; 304: 809-13.
248. CDC. HIV/AIDS Surveillance Report 2003. Atlanta: US Department of Health and Human Services, CDC; 2003.
249. UNAIDS 2004. AIDS epidemic update. Geneva: UN, 2004.
250. Quinn TC, Wawer MJ, Sewankambo N et al.Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921-9.
251. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
252. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000; 74: 6087-95.
253. Spira AI, Marx PA, Patterson BK et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996; 183: 215-25.
254. Collins KB, Patterson BK, Naus GJ et al. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 2000; 6: 475-9.
255. Gupta P, Collins KB, Ratner D et al. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 2002; 76: 9868-76.
256. Alfsen A, Yu H, Magerus-Chatinet A et al. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 2005; 16: 4267-79.
257. Bomsel M, Prydz K, Parton RG et al. Endocytosis in filtergrown Madin-Darby canine kidney cells. J Cell Biol 1989; 109: 3243-58.
258. van’t Wout AB, Kootstra NA, Mulder-Kampinga GA et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994; 94: 2060-7.
259. Zhu T, Mo H, Wang N et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261: 1179-81.
260. Delwart EL, Mullins JI, Gupta P et al. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998; 72: 617-23.
261. Zhu T, Wang N, Carr A et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996; 70: 3098-107.
262. Asin SN, Fanger MW, Wildt-Perinic D et al. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis 2004; 190: 236-45.
263. Asin SN, Wildt-Perinic D, Mason SI et al. Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity. 2003; 187: 1522-33.
264. Cohn MA, Frankel SS, Rugpao S et al. Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women. J Infect Dis 2001; 184: 410-17.
265. Martin HL, Richardson BA, Nyange PM et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180: 1863-8.
266. Sewankambo N, Gray RH, Wawer MJ et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-50.
267. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003; 9: 847-52.
268. Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286: 1353-7.
269. Kunz G, Beil D, Deiniger H et al. The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 1997; 424: 267-77.
270. Kunz G, Beil D, Deininger H et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996; 11: 627-32.
271. Kunz G, Noe M, Herbertz M et al. Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update 1998; 4: 647-54.
272. Parsons AK, Cone RA, Moench TR. Uterine uptake of vaginal fluids: implications for microbicides. Presented at Microbicides 2002, Antwerp, Belgium, 2002. Abstract B-175: 36.
273. Settlage DS, Motoshima M, Tredway DR. Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil Steril 1973; 24: 655-61.
274. Bagasra O, Freund M, Weidmann J et al. Interaction of human immunodeficiency virus with human sperm in vitro. J Acquir Immune Defic Syndr 1988; 1: 431-5.
275. Brogi A, Presentini R, Solazzo D et al. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Hum Retroviruses 1996; 12: 483-9.
276. Gosselin EJ, Howell AL, Schwarz L et al. Infectivity by HIV-1 of human uterine endometrial carcinoma cells. Adv Exp Med Biol 1995; 371B: 1003-6.
277. Howell AL, Edkins RD, Rier SE et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997; 71: 3498-506.
278. Tan X, Phillips DM. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus. Arch Virol 1996; 141: 1177-89.
279. Yeaman GR, Asin S, Weldon S et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 2004; 113: 524-33.
280. Yeaman GR, Howell AL, Weldon S et al. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109: 137-46.
281. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996; 10(Suppl A): S75-82.
282. Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-9.
283. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-20.
284. Duits LA, Nibbering PH, van Strijen E et al. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol 2003; 38: 59-64.
285. Ganz T. Defensins and host defense. Science 1999; 286: 420-1.
286. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14: 96-102.
287. Porter E, Yang H, Yavagal S et al. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005; 73: 4823-33.
288. Beppu Y, Imamura Y, Tashiro M et al. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses. J Biochem (Tokyo) 1997; 121: 309-16.
289. Gropp R, Frye M, Wagner TO et al. Epithelial defensins impair adenoviral infection: implication for adenovirusmediated gene therapy. Hum Gene Ther 1999; 10: 957-64.
290. Hiemstra PS, Maassen RJ, Stolk J et al. Antibacterial activity of antileukoprotease. Infect Immun 1996; 64: 4520-4.
291. Quinones-Mateu ME, Lederman MM, Feng Z et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003; 17: F39-48.
292. Tomee JF, Hiemstra PS, Heinzel-Wieland R et al. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 1997; 176: 740-7.
293. Virella-Lowell I, Poirier A, Chesnut KA et al. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 2000; 7: 1783-9.
294. Hocini H, Becquart P, Bouhlal H et al. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol 2000; 7: 515-18.
295. McNeely TB, Dealy M, Dripps DJ et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting antihuman immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96: 456-64.
296. Shugars DC, Sauls DL, Weinberg JB. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. Oral Dis 1997; 3(Suppl 1): S70-2.
297. Bleul CC, Farzan M, Choe H et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
298. Cocchi F, DeVico AL, Garzino-Demo A et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-15.
299. Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002; 14: 432-6.
300. Player MR, Maitra RK, Silverman RH et al. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense. Antivir Chem Chemother 1998; 9: 225-31.
301. Roy S, Katze MG, Parkin NT et al. Control of the interferoninduced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 1990; 247: 1216-19.
302. Schroder HC, Kelve M, Muller WE. The 2-5A system and HIV infection. Prog Mol Subcell Biol 1994; 14: 176-97.
303. Sobol RW, Fisher WL, Reichenbach NL et al. HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates. Biochemistry 1993; 32: 12112-18.
304. Clemens MJ, Williams BR. Inhibition of cell-free protein synthesis by pppA2‘p5‘A2‘p5‘A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 1978; 13: 565-72.
305. Farrell PJ, Balkow K, Hunt T et al. Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis. Cell 1977; 11: 187-200.
306. Jorgenson RL, Young SL, Lesmeister MJ et al. Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. Hum Immunol 2005; 66: 469-82.
307. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996; 219: 339-49.
308. Koch JU. Sperm migration in the human female genital tract with and without intrauterine devices. Acta Eur Fertil 1980; 11: 33-60.
309. Nelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975; 115: 1650-6.
310. Pioli PA, Weaver LK, Schaefer TM et al. Lipopolysaccharideinduced IL-1β production by human uterine macrophages upregulates uterine epithelial cell expression of human β- defensin 2. J Immunol 2006; 176: 6647-55.